The drug candidate, which was identified using the Ligand Activated Therapy (LAT) approach, is the second product in the company’s pain therapy range. KP511 demonstrated superior pharmacological characteristics
The open label, multicenter phase I/II study comprising 20 patients evaluated the tolerability and efficacy of OvaSave, an antigen-specific regulatory T cell-based immunotherapy. The data demonstrated that OvaSave
DAC HYP, a humanized monoclonal antibody, is subcutaneous formulation of daclizumab which binds to CD25, a receptor subunit that is expressed at high levels on T cells that
The system, which features latest information management technology, is said to help pharma professionals access and use data across the entire drug research and development life cycle, Reuters
Previously, Liu served at Irvine – based eGene as founder and CEO and set the company for acquisition by Qiagen in 2007. He has experience in bio-products development,
Adams & Knight provides integrated services to healthcare, financial, consumer and technology industries. Under the collaboration, Adams & Knight will handle Viagra patient, physician, and pharmacist communications in
The research center will comprise international, collaborative research projects between researchers at the Molecular Sciences Institute (MSI) of Berkeley, California and VTT Technical Research Centre of Finland. The
Olanzapine Tablets are generic forms of Eli Lilly’s Zyprexa used to treat schizophrenia and bipolar disorder. Teva has formulated Olanzapine Tablets in 2.5 mg, 5 mg, 7.5 mg,
Heplisav is an investigational adult hepatitis B vaccine, which in earlier Phase 3 trials, showed increased, rapid protection with fewer doses than current licensed vaccines. Both the studies
The research will be led by the Director of the Breast Oncology Program, Daniel F Hayes for his work on behalf of the North American Breast Cancer Group
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.